Sussex Research Laboratories Inc. to Exhibit at TIDES USA 2022: Oligonucleotide & Peptide Therapeutics

Date published: May 4, 2022

Sussex Research Laboratories Inc., leading GalNAc and glycopeptide specialist, is excited to announce sponsorship of TIDES USA 2022: Oligonucleotide & Peptide Therapeutics!

For over 25 years, we have enabled application of complex carbohydrate systems, including GalNAc and glycopeptides, in drug discovery, drug delivery, drug targeting, glycoconjugate vaccine development, immunotherapy, therapeutic enhancement and diagnostic/bio-analytical assay development. Visit us at booth 102 from May 9-12, 2022 at the Hynes Convention Center in Boston, Massachusetts, USA! You can also look us up on the TIDES Connectme app.

About Sussex Research Laboratories Inc.: Sussex Research Laboratories Inc. is a global leader in the design and synthesis of complex carbohydrates and stable isotope-labeled molecules that enable access to systems for the advancement of modern drug discovery and development. Through design, synthesis and characterization of molecules that incorporate glycotechnology, the company’s unique synthesis capabilities and product portfolio of glycans, glycosylated ligands, glycoamino acids, glycopeptides, glycolipids and glycoconjugates enable researchers across a variety of scientific disciplines to readily explore and exploit glycobiology in order to enhance the therapeutic potential of peptides, proteins, antibodies, lipids and oligonucleotides. For more information visit